Evaluating the implementation and effectiveness of a digital mental health intervention for psychiatric outpatient care in Canada and Brazil

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:0 publications

Grant number: 497738

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    2023
  • Known Financial Commitments (USD)

    $99,991.26
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principal Investigator

    Parkington Karisa B
  • Research Location

    Canada
  • Lead Research Institution

    St. Michael's Hospital (Toronto, Ontario)
  • Research Priority Alignment

    N/A
  • Research Category

    Secondary impacts of disease, response & control measures

  • Research Subcategory

    Indirect health impacts

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Background: The COVID-19 pandemic led to increased rates of depression and anxiety and inequalities in the delivery of psychiatric outpatient services on a global scale. Digital mental health interventions (DMHIs) address this service gap by increasing access to care through mobile apps. Remote measurement-based care (RMBC) is an effective DMHI that monitors symptoms using clinical measures and/or patient sensor data in the real world. However, barriers to DMHI implementation persist and there is limited evidence evaluating DMHI effectiveness in diverse sociocultural contexts. Method: This clinical trial will examine the implementation and effectiveness of the Digital Intervention & Intelligence Group (DiiG) app in Canadian and Brazilian psychiatric outpatient settings. The DiiG app monitors weekly self-reports (depression, anxiety, well-being) and continuous sensor recordings. A user-informed approach will refine the DiiG app to meet the needs of marginalized populations. Patients (n = 100 per site) with major depressive disorder and/or anxiety disorders will participate in a single-arm implementation-effectiveness trial with follow-up at 6-months. Clinicians (n = 10 per site) will engage in pre-/post-implementation interviews exploring their experiences with DiiG implementation. Objectives: 1) Evaluate the DiiG implementation process in marginalized populations. 2) Assess the impact of DiiG on mental health outcomes and COVID-19 impact. 3) Explore DiiG implementation and effectiveness across sociocultural contexts. Predictions: DiiG will be positively received, with a high trial completion rate. Improvements will be seen over 6-months in mental health outcomes and COVID-19 impact, with high satisfaction in care. Impact: This research will generate new evidence informing DMHI implementation in diverse sociocultural contexts, critical for clinical decision-making and policy changes in Canadian and global mental health care in post-pandemic contexts.